⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKRO News
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders
prnewswire.com
EA
HSII
AKRO
Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
AKRO
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
globenewswire.com
AKRO
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025
globenewswire.com
AKRO